/Investor DB

Rhia Ventures

1 people tracked

Find your way into Rhia Ventures

Each arrow is one introduction. Sign up to fill in the first one.

110 people can intro you to Erika

Ask Jacob VanderZwaag to introduce you to Erika Seth Davies

You →Jacob · together at Beeck Center for Social Impact + Innovation →Erika

Sign up to find every way you can get introduced to Rhia Ventures

  • Your email: who you already know at Rhia Ventures, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Rhia Ventures team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Hybrid nonprofit-venture inside a 501(c)(3) that screens mission alignment and equity impact before diligence, using philanthropic, racial-equity and clinical expertise to advise on reproductive-health policy and workforce impact.

Leads rounds
Follows
Tracked investments
5
Acquisitions
1

Team · 1 people

from curated

What they invest in

from 5 of 5 portfolio companies

Digital Health ×4FemTech ×3Healthtech ×3AI & Machine Learning ×2Biotech ×2Medical Devices ×2Direct to Consumer ×1Enterprise Software ×1

HQs:United States×4

Investments · 5 tracked

founders shown can be your intro path
Raydiant Oxymetryraydiantoximetry.comin✓ verified

Raydiant Oximetry is developing technology to reduce complications and emergency interventions during childbirth.

Digital HealthFemTechHealthtechMedical DevicesSan Ramon, US

Neil P. Ray(Executive Officer, Director)inMichael Nagel(Chief Executive Officer)in

BoardCharles McDonald(Director)John Maroney(Director)

Co-investorsAvestria VenturesBand of AngelsFemHealth VenturesSteelSky VenturesTri-Valley VenturesBill & Melinda Gates Foundation+6 more

AOA Dxaoadx.comin𝕏Seed

AOA Dx develops a blood-based liquid biopsy platform using mass spectrometry and machine learning to detect ovarian cancer at early stages through tumor-associated biomarkers in serum.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesDenver, US

Oriana Papin-Zoghbi(Founder)inAlex Fisher(Founder/COO)inAnna Jeter(Founder)inOriana Zoghbi-Harb(Executive Officer, Director)Abigail Mcelhinny(Executive Officer)in

BoardSurbhi Sarna(Director)in

Co-investorsAlleyCorpGood Growth CapitalJoyance PartnersY CombinatorAstiaAurum Venture Partners+36 more

Cirqlecirqle.bioin𝕏

Cirqle is developing a hormone-free, on-demand contraceptive that uses a molecule to reinforce the natural cervical mucus barrier and block sperm.

BiotechDigital HealthFemTech

Frederik Petursson Madsen(Co-founder)in

Co-investorsForeground Capital

NURXnurx.comin𝕏Series CAcquired

Nurx provides accessible and affordable medications and tests through a digital health platform designed for everyone.

Digital HealthDirect to ConsumerFemTechHealthtechWellness & FitnessNew York City, US

Edvard Engesaeth(Founder)Varsha Raoin

Co-investorsAlumni VenturesComcast VenturesDreamers VCFifty YearsForeground CapitalGarage Capital+16 more

Raydiantraydiant.com𝕏Nov 2021 · $5M

Displai (Raydiant) provides digital signage, employee experience tools, and location analytics powered by AI for brick-and-mortar and enterprise businesses.

AI & Machine LearningEnterprise SoftwareRetail TechSaaSSan Francisco, US

Chester Ng(Executive Officer, Director)inBobby Marhamat(Executive Officer, Director)Tuan Ho(Executive Officer)in

BoardJack Abraham(Executive Officer, Director)in

Co-investorsBeaconsfield CapitalBloomberg BetaFernbrook Capital ManagementNextView VenturesOverton Venture CapitalTransmedia Capital+12 more

Frequently asked questions

How many investments has Rhia Ventures made?
Rhia Ventures has 5 tracked investments, 1 of which have exited.
What sectors does Rhia Ventures focus on?
Rhia Ventures focuses on Biotech, Consumer, Healthtech, Impact & Social Good, Medical Devices.
Does Rhia Ventures lead rounds?
Rhia Ventures typically participates in rounds rather than leading them.

Similar investors

Featured in lists